Christina Bridges, DPM
Podiatry · San Leandro
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 9 years
- California School of Podiatric Medicine, 2017
Offices
2 locations · Bay Area Foot Care Inc · Gateway Foot and Ankle Center Plc
Hospitals listed: Jennie Stuart Medical Center · Vanderbilt Clarksville Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bridges’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Jennie Stuart Medical CenterHopkinsville, KYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Quorum Health Corporation, which runs 39 hospitals in 23 statesPatients rate it 3 of 5 · 56% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- Vanderbilt Clarksville HospitalClarksville, TNAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Community Health Systems, which runs 81 hospitals in 15 statesPatients rate it 2 of 5 · 38% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.273, Oct 2024 – Sep 2025
See every measure and the patient survey for Jennie Stuart Medical Center
Behind the star rating — Deaths: 0 better, 3 the same, 2 worse of 5 measures. Safety: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 204 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.53 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 11.4 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 17.5 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 21.4 · 223 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15 · 69 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.8 · 794 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,652 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (0.64 to 5.64) · 245 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.24 (0.54 to 3.94) · 230 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.12 (0 to 16) · 78 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.07 (0.8 to 9.34) · 56 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0 to 1.88) · 1,391 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 43 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 2.007 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.028 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 154 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.4 · 114 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 45.4 · 219 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 256 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (3.9 to 8.7) · 102 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.5 (5.8 to 12) · 102 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 51 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 85 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10.3 to 17.7) · 849 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 257 cases | No different | Jan 2024 – Dec 2024 |
What patients said (415 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 61% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 56% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Vanderbilt Clarksville Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 3 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 3 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.273 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 616 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.58 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.78 (117.2 to 216.36) · 60 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 11.1 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.7 · 222 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 22.8 · 480 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.4 · 203 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.6 · 2,314 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.02 to 0.45) · 4,599 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 4,557 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.02 (1.78 to 6.27) · 988 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.53 (0 to 3.18) · 249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.88 to 4.02) · 958 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (1.14 to 16.33) · 280 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.61 (0.54 to 8.69) · 213 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.36) · 3,345 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 32 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.269 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.259 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 9.6 · 153 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 10.8 · 243 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.4 · 494 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.4 · 665 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.1 (8.4 to 14.6) · 1,262 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 292 cases | No different | Jan 2024 – Dec 2024 |
What patients said (640 patients answered, 14% of those asked)
| Cleanliness | 2 |
| Nurse communication | 1 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 1 |
| Quietness | 2 |
| Recommend hospital | 1 |
| Room was "always" clean | 60% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 52% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 76% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 44% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 38% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$237,725
Medicare paid this office $237,725 for 415 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 177 | $18,113 | $85 |
| Short return visit (20+ min) | 109 | $14,183 | $59 |
| Removal of skin and tissue, 20.0 sq cm or less | 27 | $9,832 | $64 |
| New patient visit (45+ min) | 85 | $8,726 | $103 |
| Application of walking cast covering foot, ankle, and lower leg | 13 | $8,719 | $85 |
See all 23 services
| Return visit (30+ min) | 177 | $18,113 | $85 |
| Short return visit (20+ min) | 109 | $14,183 | $59 |
| Removal of skin and tissue, 20.0 sq cm or less | 27 | $9,832 | $64 |
| New patient visit (45+ min) | 85 | $8,726 | $103 |
| Application of walking cast covering foot, ankle, and lower leg | 13 | $8,719 | $85 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 20 | $7,249 | $48 |
| Removal of fingernails or toenails, 6 or more nails | 135 | $7,112 | $28 |
| Removal of noncancer thickened skin growth, 2-4 growths | 65 | $6,077 | $51 |
| Removal of fingernails or toenails, 1-5 nails | 115 | $4,469 | $21 |
| Removal of noncancer thickened skin growth, 1 growth | 63 | $4,351 | $43 |
| Trimming of dystrophic nails, any number | 187 | $4,143 | $12 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 13 | $3,836 | $38 |
| X-ray of foot, minimum of 3 views | 87 | $3,275 | $23 |
| Fluorescence wound imaging for bacteria, first anatomic site | 13 | $2,387 | $75 |
| Removal of tissue from wound, 20.0 sq cm or less | 12 | $2,297 | $66 |
| Complete ultrasound study of arm and leg arteries | 24 | $2,104 | $88 |
| Biopsy of fingernail or toenail | 24 | $1,730 | $67 |
| Short return visit | 47 | $1,693 | $31 |
| Destruction of skin growth, 1-14 growths | 14 | $1,581 | $66 |
| Test or measurement for functional capacity, each 15 minutes | 28 | $1,131 | $20 |
| Ultrasound study of arm and leg arteries | 14 | $813 | $58 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $27 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 19 | $4 | None |
Procedures Medicare counted
| Removal of nail tissue | 861 | More than 90% of doctors who do this |
| Removal of skin lesions | 23 | More than 66% of doctors who do this |
| Removal of tissue | 215 | More than 92% of doctors who do this |
| Removal or shaving of skin growth | 262 | More than 92% of doctors who do this |
| Skin biopsy | 1-10 | None |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Removal of fingernails or toenails, 6 or more nails | 31 | 170 | 12 | 179 | 253 |
| Removal of fingernails or toenails, 1-5 nails | – | – | – | 199 | 215 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | – | – | 22 | 224 | 150 |
| Removal of skin and tissue, 20.0 sq cm or less | – | – | 21 | 136 | 154 |
| Application of walking cast covering foot, ankle, and lower leg | – | – | – | 151 | 102 |
| Removal of noncancer thickened skin growth, 2-4 growths | – | – | – | 97 | 120 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
415 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 16% · Women 54% · Also on Medicaid 8% · Health risk score 1.52. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 59% · Chronic kidney disease 37% · Coronary heart disease 29% · Heart failure 25% · Depression 25% · COPD 23% · Atrial fibrillation 22% · Cancer 13% · Dementia 12% · Stroke 10%.
The office billed $685,744, Medicare allowed $313,163 and paid $237,725; for 9,904 services of 84 kinds; $97,826 of it was for drugs given in the office and $139,899 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 415 | 9,904 | 75 | 1.52 | $685,744 | $237,725 |
| 2023 | 429 | 27,445 | 74 | 1.68 | $1,911,609 | $925,747 |
| 2022 | 109 | 2,485 | 72 | 1.75 | $209,972 | $78,592 |
| 2021 | 101 | 450 | 74 | 2.77 | $60,392 | $13,451 |
| 2020 | 37 | 75 | 75 | 2.19 | $10,590 | $2,024 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 28 services
| Capsaicin 8% patch, per square centimeter | 16 | $59,438 | None |
| Short return visit (20+ min) | 168 | $19,880 | $64 |
| New patient visit (45+ min) | 136 | $13,439 | $99 |
| Return visit (30+ min) | 131 | $13,188 | $90 |
| Application of walking cast covering foot, ankle, and lower leg | 18 | $12,873 | $85 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 27 | $11,247 | $50 |
| Removal of skin and tissue, 20.0 sq cm or less | 36 | $10,244 | $75 |
| Destruction of peripheral nerve or branch | 15 | $6,145 | $256 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 17 | $5,525 | $38 |
| Removal of fingernails or toenails, 6 or more nails | 110 | $5,325 | $30 |
| Removal of noncancer thickened skin growth, 2-4 growths | 58 | $5,193 | $54 |
| Short return visit | 88 | $5,069 | $41 |
| Complete ultrasound study of arm and leg arteries | 50 | $4,728 | $91 |
| Removal of fingernails or toenails, 1-5 nails | 109 | $4,567 | $23 |
| Trimming of dystrophic nails, any number | 185 | $4,248 | $13 |
| X-ray of foot, minimum of 3 views | 103 | $3,979 | $23 |
| Removal of tissue from wound, 20.0 sq cm or less | 29 | $3,858 | $71 |
| Fluorescence wound imaging for bacteria, first anatomic site | 13 | $3,172 | $117 |
| Destruction of skin growth, 1-14 growths | 25 | $2,854 | $77 |
| Removal of noncancer thickened skin growth, 1 growth | 39 | $2,708 | $48 |
| Biopsy of fingernail or toenail | 32 | $2,589 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,518 | $117 |
| Ultrasonic guidance for needle placement | 19 | $1,355 | $42 |
| Test or measurement for functional capacity, each 15 minutes | 31 | $1,349 | $22 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 16 | $850 | $31 |
| Injection into tendon or ligament | 13 | $666 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $60 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 26 | $8 | None |
2022: 11 services
| New patient visit (45+ min) | 29 | $3,340 | $115 |
| Return visit (30+ min) | 24 | $2,199 | $92 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $1,922 | $92 |
| Short return visit (20+ min) | 25 | $1,835 | $63 |
| Complete ultrasound study of arm and leg arteries | 11 | $1,026 | $93 |
| Short return visit | 17 | $993 | $41 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 12 | $840 | $38 |
| Removal of noncancer thickened skin growth, more than 4 growths | 11 | $810 | $68 |
| X-ray of foot, minimum of 3 views | 16 | $499 | $24 |
| Removal of fingernails or toenails, 6 or more nails | 12 | $392 | $33 |
| Trimming of dystrophic nails, any number | 11 | $148 | $11 |
2021: 6 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 66 | $3,703 | $35 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 68 | $3,508 | $31 |
| Removal of fingernails or toenails, 6 or more nails | 58 | $2,956 | $36 |
| Removal of fingernails or toenails, 6 or more nails | 55 | $1,476 | $17 |
| Trimming of fingernails or toenails | 13 | $205 | $11 |
| Trimming of fingernails or toenails | 15 | $122 | $6 |
2020: 2 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 37 | $1,323 | $36 |
| Removal of fingernails or toenails, 6 or more nails | 31 | $644 | $21 |
Medicaid work
$1,807 in 2024
Medicaid paid $1,807 for 131 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 68 | $1,006 |
| Return visit (30+ min) | 21 | $437 |
| X-RAY EXAM OF FOOT | 28 | $275 |
| Trimming of dystrophic nails, any number | 14 | $89 |
| 2024 | 131 | 4 | 15 | $1,807 |
| 2023 | 413 | 5 | 21 | $5,981 |
| 2022 | 35 | 2 | 14 | $745 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 61 | $2,702 |
| Short return visit (20+ min) | 191 | $2,190 |
| Short return visit | 56 | $606 |
| Trimming of dystrophic nails, any number | 87 | $283 |
| X-RAY EXAM OF FOOT | 18 | $201 |
2022
| New patient visit (45+ min) | 14 | $577 |
| Short return visit (20+ min) | 21 | $168 |
Drugs they prescribed that Part D paid
$22,732
Pharmacies billed $22,732 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 8% of their Part D prescriptions (18 of 225) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
217 generic and fewer than 11 brand-name prescriptions · $22,732 in drug cost · 34 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ketoconazole | 25 | $777 | $31 |
| Duloxetine | 29 | $311 | $11 |
| Terbinafine | 35 | $307 | $9 |
| Gabapentin | 21 | $223 | $11 |
| Doxycycline Monohydrate | 15 | $95 | $6 |
See all 8 drugs
| Ketoconazole | 25 | $777 | $31 |
| Duloxetine | 29 | $311 | $11 |
| Terbinafine | 35 | $307 | $9 |
| Gabapentin | 21 | $223 | $11 |
| Doxycycline Monohydrate | 15 | $95 | $6 |
| Methylprednisolone | 11 | $70 | $6 |
| Hydrocodone-Acetaminophen | 13 | $67 | $5 |
| Meloxicam | 12 | $51 | $4 |
Year by year
| 2024 | 225 | 104 | 8% (18) | None | $22,732 |
| 2023 | 266 | 116 | 6% (17) | 5% | $15,548 |
| 2022 | 62 | 45 | None | None | $7,158 |
| 2021 | 31 | 18 | None | 0% | $362 |
| 2020 | 24 | 14 | None | 0% | $464 |
| 2019 | 32 | 27 | 34% (11) | None | $552 |
| 2018 | 31 | 23 | 45% (14) | None | $374 |
| 2017 | 17 | 13 | None | 0% | $216 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Ketoconazole | 28 | $1,693 | $60 |
| Terbinafine | 43 | $587 | $14 |
| Gabapentin | 36 | $427 | $12 |
| Methylprednisolone | 20 | $230 | $12 |
| Doxycycline Monohydrate | 16 | $189 | $12 |
| Duloxetine | 11 | $142 | $13 |
| Meloxicam | 20 | $76 | $4 |
| Oxycodone-Acetaminophen | 11 | $27 | $2 |
2022: 1 drug
| Terbinafine | 12 | $176 | $15 |
Money from drug and device companies
$1,607 in 2025
| 2025 | 17 | 29 | None | $1,607 |
| 2024 | 14 | 24 | None | $488 |
| 2023 | 14 | 37 | None | $2,331 |
| 2022 | 9 | 23 | None | $694 |
| 2021 | 7 | 24 | None | $3,149 |
| 2020 | 2 | 2 | None | $49 |
| 2019 | 8 | 17 | None | $2,725 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medical Device Business Services | Motoband | $854 | 4 payments
|
| Kerecis | Kerecis Surgiclose | $170 | 4 payments
|
| Stryker | Ortholoc 2 Lapifuse | $131 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $84 | 4 payments
|
| DePuy Synthes Sales | Motoband | $80 | 2 payments
|
| Treace Medical Concepts | Tmc Psi Cut Guide System | $65 | 2 payments
|
See all 29 published payments
| Paratek Pharmaceuticals | Meals · 2025-12-02 | Nuzyra | $24 |
| Urgo Medical North America | Meals · 2025-11-11 | Urgok2 | $18 |
| Medical Device Business Services | Meals · 2025-10-11 | Motoband | $35 |
| Medical Device Business Services | Meals · 2025-10-11 | Motoband | $59 |
| Medical Device Business Services | Travel · 2025-10-11 | Motoband | $680 |
| Medical Device Business Services | Travel · 2025-10-11 | Motoband | $80 |
| DePuy Synthes Sales | Meals · 2025-10-11 | Motoband | $65 |
| Stryker | Meals · 2025-09-25 | Ortholoc 2 Lapifuse | $131 |
| Kerecis | Meals · 2025-09-25 | Kerecis Surgiclose | $76 |
| Bioventus | Meals · 2025-09-20 | Exogen Ultrasound Bone Healing System | $18 |
| Treace Medical Concepts | Meals · 2025-09-15 | Tmc Psi Cut Guide System | $36 |
| Tactile Systems Technology | Meals · 2025-09-05 | Flexitouch Plus | $18 |
| Kerecis | Meals · 2025-08-29 | Kerecis Surgiclose | $42 |
| Solventum | Meals · 2025-08-21 | V.A.C.Instill | $14 |
| Vertex Pharmaceuticals | Meals · 2025-07-18 | Journavx | $27 |
| Smith+Nephew | Meals · 2025-07-17 | Grafix Pl | $20 |
| Amgen | Meals · 2025-07-11 | Krystexxa | $16 |
| Treace Medical Concepts | Meals · 2025-07-07 | Lapiplasty System 1 | $29 |
| CashFlow Solutions | Meals · 2025-06-13 | Lympha Press Optimal Plus(US) Bt | $19 |
| Paratek Pharmaceuticals | Meals · 2025-06-12 | Nuzyra | $23 |
| Paratek Pharmaceuticals | Meals · 2025-05-20 | Nuzyra | $21 |
| Kerecis | Meals · 2025-05-16 | Kerecis Surgiclose | $33 |
| Bioventus | Meals · 2025-04-05 | Exogen Ultrasound Bone Healing System | $23 |
| Kerecis | Meals · 2025-03-14 | Kerecis Surgiclose | $19 |
| MIMEDX Group | Meals · 2025-03-13 | None | $15 |
| Paratek Pharmaceuticals | Meals · 2025-03-11 | Nuzyra | $15 |
| Orthofix Medical | Meals · 2025-02-25 | Physio-Stim | $8 |
| Globus Medical | Meals · 2025-02-14 | Senza | $27 |
| DePuy Synthes Sales | Meals · 2025-01-22 | Motoband | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $488
| Averitas Pharma | Qutenza | $102 | 4 payments
|
| Kerecis | Kerecis Omega3 Surgiclose | $64 | 2 payments
|
| Abbvie | Dalvance | $61 | 3 payments
|
| Paratek Pharmaceuticals | Nuzyra | $42 | 2 payments
|
| Abbott Laboratories | Octrode | $41 | 2 payments
|
| Urgo Medical North America | Urgok2 | $35 | 2 payments
|
| Smith+Nephew | Stravix | $24 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $23 | 1 payment
|
| Amgen | Krystexxa | $20 | 1 payment
|
| Orthofix Medical | Physio-Stim | $20 | 1 payment
|
| Advanced Oxygen Therapy | Topical Oxygen Chamber for Extremities | $16 | 1 payment
|
| Solventum | 3m Coban | $15 | 1 payment
|
| Treace Medical Concepts | Lapiplasty System | $13 | 1 payment
|
| CashFlow Solutions | Lympha Press Optimal Plus(US) Bt | $11 | 1 payment
|
2023: $2,331
| Smith+Nephew | Grafix | $1,006 | 9 payments
|
| Medical Device Business Services | None | $610 | 5 payments
|
| DePuy Synthes Sales | Minibunion | $202 | 5 payments
|
| Averitas Pharma | Qutenza | $126 | 5 payments
|
| Medtronic | Intellis Adaptivestim | $102 | 2 payments
|
| Kerecis | Kerecis Omega3 Surgiclose | $54 | 1 payment
|
| Stryker | Spy-Phi System | $40 | 1 payment
|
| Abbott Laboratories | Proclaim | $36 | 2 payments
|
| Orthofix Medical | Physio-Stim | $34 | 1 payment
|
| Sanara MedTech | Celleraterx | $33 | 2 payments
|
| AbbVie | Dalvance | $30 | 1 payment
|
| Kci USA | Activ.A.C. | $22 | 1 payment
|
| ConvaTec | Aquacel Ag+ | $20 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $17 | 1 payment
|
2022: $694
| Stryker | Easyfuse | $273 | 6 payments
|
| Smith+Nephew | Stravix | $254 | 7 payments
|
| Kci USA | Activ.A.C. | $45 | 2 payments
|
| Abbvie | Dalvance | $41 | 3 payments
|
| Triad Life Sciences | Innovamatrix Ac | $21 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $15 | 1 payment
|
| Organogenesis | Puraply | $15 | 1 payment
|
| Advanced Oxygen Therapy | Topical Wound Oxygen | $15 | 1 payment
|
| Orthofix Medical | Physio-Stim | $14 | 1 payment
|
2021: $3,149
| Arthrex | None | $1,887 | 11 payments
|
| Paragon 28 | Product Portfolio | $1,128 | 2 payments
|
| Smith+Nephew | Collagenase Santyl | $50 | 2 payments
|
| In2Bones USA | Colink | $27 | 2 payments
|
| Hartmann USA | Zetuvit Plus | $20 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $19 | 1 payment
|
| Flower Orthopedics Coporation | None | $18 | 1 payment
|
2020: $49
| Acera Surgical | Restrata Wound Matrix | $27 | 1 payment
|
| Organogenesis | Puraply | $22 | 1 payment
|
2019: $2,725
| Arthrex | None | $1,693 | 3 payments
|
| Crossroads Orthopedics | None | $517 | 2 payments
|
| Integra LifeSciences | Omnigraft | $148 | 2 payments
|
| Stryker | Allograft Bio-Implants | $143 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $86 | 1 payment
|
| Zimmer Biomet Holdings | Foot & Ankle Product Portfolio | $78 | 4 payments
|
| Organogenesis | Apligraf | $36 | 3 payments
|
| Wright Medical Technology | Bioskin | $24 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 64.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1508386038
- Licence
- TN 900
- Trained
- California School of Podiatric Medicine, 2017 · 9 years ago
- Group
- Bay Area Foot Care Inc · Gateway Foot and Ankle Center Plc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 411 30th St Ste 314, Oakland, CA, 94609
- NPI first listed
- 2017-06-26
- NPI last updated
- 2026-04-08
- NPI record certified
- 2026-04-08
This is when the NPI record was last certified, not a medical board exam.